Combined topotecan and lapatinib in patients with early recurrent ovarian or peritoneal cancer after first line of platinum-based chemotherapy: A French FEDEGYN-FNCLCC phase II trial

被引：0
|
作者：
Joly, F. [1 ,2 ,3 ,4 ,5 ,6 ]
Weber, B. [1 ,2 ,3 ,4 ,5 ,6 ]
Pautier, P. [1 ,2 ,3 ,4 ,5 ,6 ]
Fabbro, M. [1 ,2 ,3 ,4 ,5 ,6 ]
Selle, F. [1 ,2 ,3 ,4 ,5 ,6 ]
Krieger, S. [1 ,2 ,3 ,4 ,5 ,6 ]
Leconte, A. [1 ,2 ,3 ,4 ,5 ,6 ]
Bourgeois, H. [1 ,2 ,3 ,4 ,5 ,6 ]
Henry-Amar, M. [1 ,2 ,3 ,4 ,5 ,6 ]
机构：
[1] Ctr Francois Baclesse, F-14021 Caen, France
[2] Ctr Alexis Vautrin, Nancy, France
[3] Inst Gustave Roussy, Villejuif, France
[4] Ctr Val dAurelle, Montpellier, France
[5] Hop Tenon, AP HP, F-75970 Paris, France
[6] Ctr Jean Bernard, Le Mans, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5555
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma
    Weroha, S. John
    Oberg, Ann L.
    Ziegler, Katie L. Allen
    Dakhilm, Shaker R.
    Rowland, Kendrith M.
    Hartmann, Lynn C.
    Moore, Dennis F., Jr.
    Keeney, Gary L.
    Peethambaram, Prema P.
    Haluska, Paul
    GYNECOLOGIC ONCOLOGY, 2011, 122 (01) : 116 - 120
  • [2] RANDOMIZED PHASE II STUDY OF BELOTECAN OR TOPOTECAN CHEMOTHERAPY AS SECOND-LINE CHEMOTHERAPY AFTER PLATINUM-BASED FIRST-LINE CHEMOTHERAPY FOR SMALL CELL LUNG CANCER
    Yoon, S.
    Lee, D. H.
    Choi, C.
    Lee, J. C.
    Lee, J. S.
    Kim, S.
    ANNALS OF ONCOLOGY, 2014, 25
  • [3] PHASE II TRIAL OF LAPATINIB IN COMBINATION WITH WEEKLY TOPOTECAN IN PATIENTS WITH PLATINUM-REFRACTORY/RESISTANT OVARIAN AND PRIMARY PERITONEAL CARCINOMA
    Haluska, P.
    Oberg, A. L.
    Dakhil, S. R.
    Ziegler, K. L. Allen
    Rowland, K. M.
    Hartmann, L. C.
    Moore, D. F.
    Keeney, G. L.
    Peethambaram, P. P.
    ANNALS OF ONCOLOGY, 2009, 20 : 43 - 43
  • [4] A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy
    Wenham, R.
    LaPolla, J.
    Lin, H.
    Apte, S.
    Roberts, W.
    Lancaster, J.
    Theodore, S.
    Fabri, D.
    Havrilesky, L.
    Alvarez-Secord, A.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S61 - S62
  • [5] Phase II Trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy
    Wenham, R.
    LaPolla, J.
    Hui-Yi, L.
    Apte, S.
    Roberts, W.
    Lancaster, J.
    Bosquet, J. Gonzalez
    Theodore, S.
    Havrilesky, L.
    Alvarez-Secord, A.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S83 - S84
  • [6] A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy
    Wenham, Robert M.
    Lapolla, James
    Lin, Hui-Yi
    Apte, Sachin M.
    Lancaster, Johnathan M.
    Judson, Patricia L.
    Gonzalez-Bosquet, Jesus
    Herschberger, Amber
    Havrilesky, Laura J.
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2013, 130 (01) : 19 - 24
  • [7] NEOADJUVANT CHEMOTHERAPY MAY IMPAIR RESPONSE TO FIRST LINE PLATINUM-BASED CHEMOTHERAPY FOR OVARIAN CANCER PATIENTS
    Ekmann-Gade, A. W.
    Hogdall, C.
    Peen, U. B. S.
    Engelholm, S. A.
    Fago-Olsen, C. L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 675 - 676
  • [8] Taxol as second-line treatment in patients with advanced ovarian cancer after platinum-based first-line chemotherapy
    Mayerhofer, K
    Kucera, E
    Zeisler, H
    Speiser, P
    Reinthaller, A
    Sevelda, P
    GYNECOLOGIC ONCOLOGY, 1997, 64 (01) : 109 - 113
  • [9] Phase I trial of ribociclib (LEE-011) with platinum-based chemotherapy in recurrent platinum sensitive ovarian cancer
    Coffman, Lan
    Orellana, Taylor
    Normolle, Daniel
    Courtney-Brooks, Madeleine
    Boisen, Michelle
    Olawaiye, Alexander
    Berger, Jessica
    Lesnock, Jamie
    Sukumvanich, Paniti
    Taylor, Sarah
    McLean, Karen
    Uppal, Shitanshu
    Buckanovich, Ronald
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S69 - S69
  • [10] Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy
    Matsumoto, Aya
    Higuchi, Toshihiro
    Yura, Shigeo
    Mandai, Masaki
    Kariya, Masatoshi
    Takakura, Kenji
    Fujii, Shingo
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2006, 32 (06) : 580 - 587
12345